Navigation Links
Pharmasset to Present at Two Upcoming Investor Conferences
Date:11/10/2008

PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces management will present at the Rodman and Renshaw 10th Annual Global Investment Conference and the Lazard Capital Markets 5th Annual Healthcare Conference. Both conferences will be held in New York, NY.

Schaefer Price, Pharmasset's President and Chief Executive Officer, will provide an overview of the company at the Rodman and Renshaw Conference on Tuesday, November 11, 2008 at 12:25 PM (ET) and at the Lazard Capital Markets Conference on Tuesday November 18, 2008 at 8:55 AM (ET)

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm . Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm .

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for t
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmasset to Present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th
2. Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th
3. Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
4. Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences
5. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
6. Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock
7. Pharmasset Joins Russell 3000 Index
8. Pharmasset to Present at the Needham & Co. Biotechnology and Medical Technology Conference on Wednesday, June 11th
9. Pharmasset Selected to Join the NASDAQ Biotechnology Index
10. Pharmasset to Present at the Morgan Stanley Global Healthcare Conference on Wednesday, April 30th
11. Pharmasset Adds Two Cohorts to R7128 Hepatitis C Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 BCC Research reveals in ... CELLS , the global market for stem cells is ... with a five-year compound annual growth rate (CAGR) of ... Americas with growth projections of $2.2 billion in 2014 ... http://photos.prnewswire.com/prnh/20140805/700528) , Unlike other potential applications of ...
(Date:9/15/2014)... , Sept. 15, 2014   Global ... innovator of scientific products and services for satellite ... Acquisition Solution for Integrated Services (OASIS) from the ... GST was selected to provide the government best-value ... Small Business (SB) category in Pool 4. The ...
(Date:9/15/2014)... from North Carolina State University have developed a technique ... applying very low voltages, opening the door to a ... technologies. The technique hinges on the fact that the ... deposited or removed acts as a surfactant, lowering ... fluid. , The researchers used a liquid metal alloy ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Bioptigen ... deep imaging OCT system for the optical device metrology ... EnvisuTM S4410 SDOCT for Contact Lens Metrology ... standard and high complexity contact lens, IOL structures, and ... of a complete contact lens immersed in a hydration ...
Breaking Biology Technology:Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 2Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 3Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 3Researchers control surface tension to manipulate liquid metals 2Bioptigen Introduces Deep Imaging OCT System for Contact Lens Metrology 2
... media presentations created with Sonic Foundry s Mediasite ... of hosted services, which help organizations capture presentations digitally and ... service platform created exclusively for Mediasite, the companies announced in ... any size and type can leverage the power of rich ...
... Formulatrix Inc. and Bruker AXS ... protein-crystal incubation and imaging products. , ,Crystal Farm, developed ... Partners International , is an integrated product for incubation ... companies design drugs. The system will now work with ...
... the first installment - From the mind to ... - The Wisconsin Technology Council has published ... 24-page publication highlights the states research base, technology-transfer process, ... I-Q Corridor that joins Chicago, Wisconsin and Minneapolis-St. Paul. ...
Cached Biology Technology:BxVideo designs Web hosting service for Sonic Foundry media presentations 2Protein-crystal companies join forces for better imaging process 2WTC launches Wisconsin Life Science magazine 2
(Date:9/15/2014)... of Science and Technology in Society in the College ... has won a 2014 National Science Foundation Faculty Early ... of creating a global nuclear emergency response plan. , ... Plant in March 2011 was a turning point in ... Three of the plant,s six nuclear reactors melted down ...
(Date:9/15/2014)... For multicellular lifeplants and animalsto thrive in the ... the water. In certain coastal areas, extreme oxygen-starvation ... destroy food web structure. As dissolved oxygen levels ... life into microbial community metabolism resulting in impacts ... , Over the past 50 years, oxygen minimum ...
(Date:9/15/2014)... and cognitive function may play roles in one,s musical ... pitch, timbre, tone durations, and formal structure in music. ... explain that extremes in musical aptitude (extreme capacity/no capacity) ... individuals having moderate aptitude. , "This is a typical ... genes, and it is influenced to varying degrees by ...
Breaking Biology News(10 mins):'Nuclear disasters don't respect national boundaries' 2Decoding virus-host interactions in the oxygen-starved ocean 2Decoding virus-host interactions in the oxygen-starved ocean 3Decoding virus-host interactions in the oxygen-starved ocean 4Decoding virus-host interactions in the oxygen-starved ocean 5
... Sommerlad has thought a lot about the challenges of ... engineering at Newark College of Engineering in 1960. He,s ... power-plant technologies needed to produce the electricity that sustains ... recent recipient of one of six NJIT Alumni Achievement ...
... American Societies for Experimental Biology (FASEB) Minority Access to ... recipients for the 2011 Annual Biomedical Research Conference for ... November 9-12, 2011. These awards are meant to ... scientists into the mainstream of the basic science community ...
... - Although exercise is generally considered to be a ... has traditionally been considered too risky for women who ... benefits such as decreasing the risk of women developing ... high levels but how this might happen has remained ...
Cached Biology News:NJIT alum, power expert, advisor during Exxon/Valdez clean-up, gets award 2NJIT alum, power expert, advisor during Exxon/Valdez clean-up, gets award 3MARC Travel awards announced for the ABRCMS meeting 2MARC Travel awards announced for the ABRCMS meeting 3MARC Travel awards announced for the ABRCMS meeting 4MARC Travel awards announced for the ABRCMS meeting 5Exercise before and during early pregnancy increases two beneficial proteins for mothers-to-be 2
... monoclonal antibody development to targets including proteins ... DNA, and cancer-specific surface antigens. A&Gs ... is completed in approximately 40 days (duration ... of antigens). Phase I: Immunization, test ...
PCR System for increased fidelity, yield and length of PCR products. Amplifies targets up to 10 kb from human genomic DNA....
...
US Pharmacopoeia Purified-Water/Water-for-Injection Quality Water...
Biology Products: